drugset
drugset / Trial / NCT04790565

Fecal Microbiota Transplantation for Carbapenem Resistant Enterobacteriaceae

NCT04790565 ↗

Phase 2/3 Completed 15 enrolled Rambam Health Care Campus
NaSingle-groupOpen-labelTreatment

Summary

Open-label, single center, prospective interventional non-comparative study for CRE carriers.

Timeline

Start
2021-04-01
Primary completion
2022-06-30
Completion
2022-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Fecal microbiota transplantation Other / unclassified 15 unknown Oral

Indications

No indication recorded.